{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:09:27Z","timestamp":1791227367214,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.compbiolchem.2025.108828","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:14:37Z","timestamp":1765440877000},"page":"108828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["AI-powered literature mining reveals the therapeutic significance of GLP-1 receptor: Simulation of natural agonist candidates based on molecular dynamics"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6379-8994","authenticated-orcid":false,"given":"Rabia Kalkan","family":"Cakmak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6174-915X","authenticated-orcid":false,"given":"Nail","family":"Besli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0137-4963","authenticated-orcid":false,"given":"Nilufer","family":"Ercin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulkan","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2025.108828_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/cimb47040285","article-title":"The Expanding Role of GLP-1 Receptor Agonists: Advancing Clinical Outcomes in Metabolic and Mental Health","volume":"47","author":"Al Qassab","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib2","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.3390\/ijms26136131","article-title":"Structure-Based Discovery of Orthosteric Non-Peptide GLP-1R Agonists via Integrated Virtual Screening and Molecular Dynamics","volume":"26","author":"Alturki","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/jamia.2009.002733","article-title":"An overview of MetaMap: historical perspective and recent advances","volume":"17","author":"Aronson","year":"2010","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: Advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12896-025-00985-3","article-title":"Dietary compounds activates sirtuins--a computational modeling approach towards the management of ageing","volume":"25","author":"Besli","year":"2025","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151685","article-title":"Discovering the natural source-derived antihypertensive compounds aspiring current therapeutic targets by computer-based drug design","author":"Besli","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/endrev\/bnac033","article-title":"New insights into the structure and function of class B1 GPCRs","volume":"44","author":"Cary","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib8","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.drudis.2018.01.039","article-title":"The rise of deep learning in drug discovery","volume":"23","author":"Chen","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.compbiolchem.2025.108828_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200155119","article-title":"Structural basis of peptidomimetic agonism revealed by small-molecule GLP-1R agonists Boc5 and WB4-24","volume":"119","author":"Cong","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1474-4422(20)30173-3","article-title":"Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial","volume":"19","author":"Cukierman-Yaffe","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib12","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1021\/acs.jmedchem.4c01257","article-title":"Artificial intelligence in natural product drug discovery: current applications and future perspectives","volume":"68","author":"Gangwal","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib13","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3390\/pharmaceutics16121607","article-title":"Discovery of Non-Peptide GLP-1 Positive Allosteric Modulators from Natural Products: Virtual Screening, Molecular Dynamics, ADMET Profiling, Repurposing, and Chemical Scaffolds Identification","volume":"16","author":"Gomaa","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.compbiolchem.2025.108828_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/3458754","article-title":"Domain-specific language model pretraining for biomedical natural language processing","volume":"3","author":"Gu","year":"2021","journal-title":"ACM Trans. Comput. Health"},{"key":"10.1016\/j.compbiolchem.2025.108828_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1112229","article-title":"The application of metagenomic next-generation sequencing in pathogen diagnosis: a bibliometric analysis based on Web of Science","volume":"13","author":"He","year":"2023","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"10.1016\/j.compbiolchem.2025.108828_bib16","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3390\/ph17111470","article-title":"GLP-1 receptor agonists: a promising therapy for modern lifestyle diseases with unforeseen challenges","volume":"17","author":"Kupnicka","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.compbiolchem.2025.108828_bib17","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/bioinformatics\/btz682","article-title":"BioBERT: a pre-trained biomedical language representation model for biomedical text mining","volume":"36","author":"Lee","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiolchem.2025.108828_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/metabo12060549","article-title":"Investigating potential GLP-1 receptor agonists in cyclopeptides from Pseudostellaria heterophylla, Linum usitatissimum, and Drymaria diandra, and peptides derived from heterophyllin B for the treatment of type 2 diabetes: An in silico study","volume":"12","author":"Liao","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.compbiolchem.2025.108828_bib19","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.3390\/ijms21082854","article-title":"The Effects of a Weight-Loss Herbal Formula RCM-107 and Its Eight Individual Ingredients on Glucagon-Like Peptide-1 Secretion\u2014An In Vitro and In Silico Study","volume":"21","author":"Luo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib20","first-page":"5","article-title":"Incretin hormones: Their role in health and disease","volume":"21","author":"Nauck","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib21","doi-asserted-by":"crossref","unstructured":"Neumann, M., King, D., Beltagy, I., Ammar, W., 2019. ScispaCy: fast and robust models for biomedical natural language processing. arXiv Prepr. arXiv1902.07669.","DOI":"10.18653\/v1\/W19-5034"},{"key":"10.1016\/j.compbiolchem.2025.108828_bib22","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1111\/dom.15150","article-title":"Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: a Phase 1b, multicentre, blinded, placebo-controlled, randomized, multiple-ascending-dose study in people with type 2 diabetes","volume":"25","author":"Pratt","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/scipharm93020026","article-title":"Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies","volume":"93","author":"Sald\\\u2019\\ivar-Cer\u00f3n","year":"2025","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2025.2499671","article-title":"Catechins anti-diabetic actions are mediated via multiple receptors, a mechanism deduced via molecular docking and dynamic simulations","author":"Salih","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib25","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41591-021-01391-w","article-title":"Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial","volume":"27","author":"Saxena","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib26","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx\\_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib27","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3390\/molecules26051465","article-title":"Engineering of challenging G protein-coupled receptors for structure determination and biophysical studies","volume":"26","author":"Waltensp\u00fchl","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.compbiolchem.2025.108828_bib28","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.compbiolchem.2025.108828_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30153216","article-title":"Exploring Conformational Transitions in Biased and Balanced Ligand Binding of GLP-1R","volume":"30","author":"Xu","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.compbiolchem.2025.108828_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102111","article-title":"Frailty and sarcopenia: a bibliometric analysis of their association and potential targets for intervention","volume":"92","author":"Ye","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.compbiolchem.2025.108828_bib31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molcel.2020.09.020","article-title":"Differential GLP-1R binding and activation by peptide and non-peptide agonists","volume":"80","author":"Zhang","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.compbiolchem.2025.108828_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13065-024-01316-x","article-title":"Combined machine learning models, docking analysis, ADMET studies and molecular dynamics simulations for the design of novel FAK inhibitors against glioblastoma","volume":"18","author":"Zhao","year":"2024","journal-title":"BMC Chem."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147692712500492X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147692712500492X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T20:30:00Z","timestamp":1771446600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147692712500492X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":32,"alternative-id":["S147692712500492X"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108828","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-powered literature mining reveals the therapeutic significance of GLP-1 receptor: Simulation of natural agonist candidates based on molecular dynamics","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108828"}}